Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aileen Aherne

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Trends in Genetics : TIG|January 22, 2005
Light in retinitis pigmentosaAvril Kennan, Aileen Aherne, Pete Humphries
Biochimica Et Biophysica Acta|July 28, 2011
Molecular recruitment as a basis for negative dominant inheritance? propagation of misfolding in oligomers of IMPDH1, the mutated enzyme in the RP10 form of retinitis pigmentosaXiao-Tao Wang, Brian Mion, Aileen Aherne, et al.
Human Molecular Genetics|March 5, 2002
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) miceAvril Kennan, Aileen Aherne, Arpad Palfi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2005
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approachAnna-Sophia Kiang, Arpad Palfi, Marius Ader, et al.
Human Molecular Genetics|April 4, 2008
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10)Lawrence C S Tam, Anna-Sophia Kiang, Avril Kennan, et al.
Human Molecular Genetics|February 26, 2004
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosaAileen Aherne, Avril Kennan, Paul F Kenna, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Trends in Genetics : TIG|January 22, 2005
Light in retinitis pigmentosaAvril Kennan, Aileen Aherne, Pete Humphries
Biochimica Et Biophysica Acta|July 28, 2011
Molecular recruitment as a basis for negative dominant inheritance? propagation of misfolding in oligomers of IMPDH1, the mutated enzyme in the RP10 form of retinitis pigmentosaXiao-Tao Wang, Brian Mion, Aileen Aherne, et al.
Human Molecular Genetics|March 5, 2002
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) miceAvril Kennan, Aileen Aherne, Arpad Palfi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2005
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approachAnna-Sophia Kiang, Arpad Palfi, Marius Ader, et al.
Human Molecular Genetics|April 4, 2008
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10)Lawrence C S Tam, Anna-Sophia Kiang, Avril Kennan, et al.
Human Molecular Genetics|February 26, 2004
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosaAileen Aherne, Avril Kennan, Paul F Kenna, et al.
Pageof 1